P.5.d.004 Neuroprotective effect of cerebrolysin and erythropoietin versus haloperidol in an Alzheimer's disease – animal model

MLA

T. Udristoiu, et al. “P.5.d.004 Neuroprotective Effect of Cerebrolysin and Erythropoietin versus Haloperidol in an Alzheimer’s Disease – Animal Model.” European Neuropsychopharmacology, vol. 20, Aug. 2010, pp. S565–66. EBSCOhost, https://doi.org/10.1016/s0924-977x(10)70855-5.

APA

T. Udristoiu, L. Mogoanta, D. Marinescu, D. Pirici, & Ion Udristoiu. (2010). P.5.d.004 Neuroprotective effect of cerebrolysin and erythropoietin versus haloperidol in an Alzheimer’s disease – animal model. European Neuropsychopharmacology, 20, S565–S566. https://doi.org/10.1016/s0924-977x(10)70855-5

Chicago

T. Udristoiu, L. Mogoanta, D. Marinescu, D. Pirici, and Ion Udristoiu. 2010. “P.5.d.004 Neuroprotective Effect of Cerebrolysin and Erythropoietin versus Haloperidol in an Alzheimer’s Disease – Animal Model.” European Neuropsychopharmacology 20 (August): S565–66. doi:10.1016/s0924-977x(10)70855-5.